BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6121 related articles for article (PubMed ID: 3085523)

  • 1. Leu-M1 antigen in human neoplasms. An immunohistologic study of 400 cases.
    Sheibani K; Battifora H; Burke JS; Rappaport H
    Am J Surg Pathol; 1986 Apr; 10(4):227-36. PubMed ID: 3085523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leu M1 and S100 in Hodgkin's disease and non-Hodgkin's lymphomas.
    Kornstein MJ; Bonner H; Gee B; Cohen R; Brooks JJ
    Am J Clin Pathol; 1986 Apr; 85(4):433-7. PubMed ID: 3754087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leu M1 and peanut agglutinin stain the neoplastic cells of Hodgkin's disease.
    Hsu SM; Jaffe ES
    Am J Clin Pathol; 1984 Jul; 82(1):29-32. PubMed ID: 6741873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of combining antigranulocyte with antileukocyte antibodies in differentiating Hodgkin's disease from non-Hodgkin's lymphoma.
    Medeiros LJ; Weiss LM; Warnke RA; Dorfman RF
    Cancer; 1988 Dec; 62(12):2475-81. PubMed ID: 2973368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of T-cell antigens on Reed-Sternberg cells in a subset of patients with nodular sclerosing and mixed cellularity Hodgkin's disease.
    Kadin ME; Muramoto L; Said J
    Am J Pathol; 1988 Feb; 130(2):345-53. PubMed ID: 2963547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues.
    Pinkus GS; Thomas P; Said JW
    Am J Pathol; 1985 May; 119(2):244-52. PubMed ID: 3887932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monomorphic lymphomas arising in patients with Hodgkin's disease. Correlation of morphologic, immunophenotypic, and molecular genetic findings in 12 cases.
    Casey TT; Cousar JB; Mangum M; Williams ME; Lee JT; Greer JP; Collins RD
    Am J Pathol; 1990 Jan; 136(1):81-94. PubMed ID: 2297052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of Leu M1 monoclonal antibody in the differential diagnosis of Hodgkin's disease.
    Hyder DM; Schnitzer B
    Arch Pathol Lab Med; 1986 May; 110(5):416-9. PubMed ID: 3516118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leu-M1 immunoreactivity in nonhematopoietic neoplasms and myeloproliferative disorders. An immunoperoxidase study of paraffin sections.
    Pinkus GS; Said JW
    Am J Clin Pathol; 1986 Mar; 85(3):278-82. PubMed ID: 3092632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas. An immunohistologic analysis demonstrating the value of Leu M1 antigen.
    Sheibani K; Battifora H; Burke JS
    Am J Pathol; 1986 May; 123(2):212-9. PubMed ID: 2422942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody Leu-22 (L60) permits the demonstration of some neoplastic T cells in routinely fixed and paraffin-embedded tissue sections.
    Wieczorek R; Buck D; Bindl J; Knowles DM
    Hum Pathol; 1988 Dec; 19(12):1434-43. PubMed ID: 2973429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Leu-3a antibody reactivity with Reed-Sternberg cells of Hodgkin's disease.
    Oka K; Mori N; Kojima M
    Arch Pathol Lab Med; 1988 Feb; 112(2):139-42. PubMed ID: 3257383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leu M-1 antigen: comparative expression in Hodgkin's disease and T cell lymphoma.
    Strauchen JA; Breakstone B
    Hematol Oncol; 1987; 5(2):107-14. PubMed ID: 2885252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraffin section markers for Reed-Sternberg cells. A comparative study of peanut agglutinin, Leu-M1, LN-2, and Ber-H2.
    Ree HJ; Neiman RS; Martin AW; Dallenbach F; Stein H
    Cancer; 1989 May; 63(10):2030-6. PubMed ID: 2564804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spectrum of Leu-M1 staining in lymphoid and hematopoietic proliferations.
    Swerdlow SH; Wright SA
    Am J Clin Pathol; 1986 Mar; 85(3):283-8. PubMed ID: 2428238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the pattern of expression of Leu-M1 antigen in adenocarcinomas, neutrophils and Hodgkin's disease by immunoelectron microscopy.
    Valente AM; Taatjes DJ; Mount SL
    Histochem Cell Biol; 1995 Mar; 103(3):181-6. PubMed ID: 7553131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic expression of Hodgkin's and Reed-Sternberg cells in Hodgkin's disease.
    Hsu SM; Yang K; Jaffe ES
    Am J Pathol; 1985 Feb; 118(2):209-17. PubMed ID: 3970138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of Leu-M1 immunostaining in papillary carcinomas of the thyroid gland.
    Schröder S; Schwarz W; Rehpenning W; Löning T; Böcker W
    Virchows Arch A Pathol Anat Histopathol; 1987; 411(5):435-9. PubMed ID: 3116758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and ultrastructural study of Leu M1 antigen in Reed-Sternberg cells: comparison with granulocytes and interdigitating reticulum cells.
    Hsu SM; Huang LC; Hsu PL; Ge ZH; Ho YS; Cuttita F; Mulshine J
    J Natl Cancer Inst; 1986 Aug; 77(2):363-70. PubMed ID: 3090338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies in the diagnosis of Hodgkin's disease. The search for a rational panel.
    Chittal SM; Caverivière P; Schwarting R; Gerdes J; Al Saati T; Rigal-Huguet F; Stein H; Delsol G
    Am J Surg Pathol; 1988 Jan; 12(1):9-21. PubMed ID: 2827535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 307.